Synthesis of rhodium(III) complexes shows significant phototoxicity in melanoma cells, indicating potential for photodynamic therapy.
We report the synthesis and characterization of three half-sandwich rhodium(III) complexes incorporating anthracene and biphenyl moieties to investigate their photobiological activity. Complexes 1 and 2, bearing anthracene-based Schiff base ligand, displayed pronounced phototoxicity upon blue-light irradiation, with complex 2 achieving a phototoxicity index of 144 in A375 melanoma cells. In contrast, complex 3, lacking the anthracene unit, was photoinactive. Photoactivation of complexes 1 and 2 induced −N═CH– Schiff bond cleavage, releasing anthracene-9-carbaldehyde, as confirmed by UV–vis and mass spectrometry. Blue light also enabled catalytic oxidation of NADH to NAD+. Mechanistic studies revealed oncosis-like cell death mediated by reactive oxygen species. Both complexes retained activity in 3D tumor spheroids, demonstrating efficient tissue penetration. These results identify anthracene-functionalized rhodium(III) complexes as promising candidates for photodynamic therapy and provide, to our knowledge, the first detailed mechanistic insight into photopotentiation in half-sandwich rhodium systems.
No takes yet. Share an insight, caveat, or question.
Andršová et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: